title: Recent trends in reperfusion in ST elevation myocardial infarction in a South Indian tier-3 city.
abstract: OBJECTIVE
  In India, larger proportions of patients with ACS present with STEMI. We sought to study the recent trends of reperfusion in patients of acute STEMI.
  
  
  RESULTS
  1905 patients presenting with acute STEMI enrolled. 1636 (86%) received some form of reperfusion therapy. Streptokinase, 1235 (65%) patients, was the most common mode of reperfusion therapy used followed by primary PCI (205, 10.7%) and tenecteplase (196, 10%). 269 (14%) did not receive any form of reperfusion therapy, the most common reason being late presentation in 230 (85.7%). Patients presenting with STEMI increased from 297 to 446 comparing first and last half-year of study period. The PCI and tenecteplase numbers increased from 19 to 68 and 27 to 97 respectively.
  
  
  CONCLUSIONS
  There was 20% increase in STEMI every year. Younger patients are least likely to receive primary PCI or tenecteplase. 1 in 8 patients of STEMI did not receive any form of reperfusion therapy.
authors.affiliation: Department of Cardiology, Christian Medical College and Hospital, Tamil Nadu, India. kunwar_brajesh@yahoo.com
authors.forename: Brajesh Kumar
authors.initials: BK
authors.lastname: Kunwar
authors.forename: Amit
authors.initials: A
authors.lastname: Hooda
authors.forename: George
authors.initials: G
authors.lastname: Joseph
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000639:trends*; D012189:Retrospective Studies; D013300:Streptokinase / Q000008:administration & dosage; D000077785:Tenecteplase; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014505:Urban Population
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase